Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.1%

2 terminated out of 28 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

21%

6 trials in Phase 3/4

Results Transparency

39%

7 of 18 completed with results

Key Signals

7 with results90% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (17)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (4)

Trial Status

Completed18
Unknown6
Withdrawn2
Terminated2

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (28)

Showing 20 of 20 trials
NCT02259413Not ApplicableCompleted

Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis

NCT01181544Not ApplicableCompletedPrimary

A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis

NCT01722695Not ApplicableCompletedPrimary

Performance Comparison of Revaclear With Larger Dialyzer

NCT00890045Not ApplicableCompletedPrimary

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

NCT01421771Not ApplicableCompleted

Blood Pressure in Dialysis Patients

NCT01947673Not ApplicableCompletedPrimary

Mechanisms of Intradialytic Hypertension

NCT02685995Not ApplicableCompletedPrimary

VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC

NCT01982864Phase 4TerminatedPrimary

Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.

NCT02825589Not ApplicableCompletedPrimary

BIA-Guided Dry Weight Assessment on Sleep Quality in Chronic Hemodialysis Patients

NCT03634904Not ApplicableUnknown

Serum Ceftazidime Concentrations in Hemodialysis Patients

NCT01981603Not ApplicableCompleted

Transplant Navigator Dissemination

NCT00882557Phase 1Completed

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

NCT02583347UnknownPrimary

Sleep Disturbance in Patients With End-Stage Renal Disease

NCT01320202Phase 3CompletedPrimary

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

NCT01322347Phase 3CompletedPrimary

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)

NCT01312441Phase 4Terminated

Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D

NCT02285075Phase 4Completed

Temocillin Pharmacokinetic in Hemodialysis

NCT01015313Not ApplicableWithdrawnPrimary

Effects of Intensified Sodium Management in Hemodialysis Patients

NCT02452788Not ApplicableUnknown

Pharmaceutical Care in Ambulatory Hemodialysis Patients

NCT01946841Phase 2Withdrawn

Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life

Scroll to load more

Research Network

Activity Timeline